The main change is spending, not output. Murphy raised its 2026 capital plan to $1.5-$1.6 billion from the prior $1.25 billion midpoint, a $300 million increase, while keeping full-year production at 167,000-175,000 BOEPD, or a 171,000 BOEPD midpoint. The higher spending is aimed at Bubale appraisal, Eagle Ford acceleration and Chinook development rather than repairing an operational shortfall. The capex increase had already been disclosed with second-quarter results, so this presentation largely confirms rather than surprises the market.
| Measure | Current filing | Prior / comparison |
|---|---|---|
| FY 2026 production | 167-175 MBOEPD | 171 MBOEPD midpoint |
| FY 2026 capex | $1.5-$1.6B | $1.25B prior midpoint |
| 3Q 2026 production | 171-179 MBOEPD | — |
| 2Q adjusted net income/share | $1.55 | $0.27 a year ago |
| 2Q free cash flow | $110M | $17.8M a year ago |
| Net debt at June 30 | $1.067B | — |
The incremental capital has a credible growth rationale, but near-term returns are deferred. Murphy assigns $100 million to the Bubale-1X discovery, $90 million to the Bubale West appraisal, $70 million to Eagle Ford acceleration and $40 million to Chinook #8. Management says the Eagle Ford work should add approximately 6 MBOEPD in 2027, while Chinook is expected online in 4Q 2026. Those benefits are future-dated, so the filing increases the investment case without increasing current-year production guidance.
The balance sheet can absorb the plan, but shareholder returns compete with reinvestment. Murphy reported $2.5 billion of liquidity, 0.9x leverage, $110 million of second-quarter free cash flow and $50 million returned to shareholders. It also reiterated that at least 50% of adjusted free cash flow is allocated to shareholders, but the added exploration and development spending means less flexibility for debt reduction or repurchases if commodity prices weaken.
Execution milestones remain the cleaner positive signal. Lac Da Vang remains on track for first oil in 4Q 2026, with the FSO, pipeline work and platform topsides progressing on schedule; Hai Su Vang has moved into development planning, and Bubale has advanced into appraisal. 〔0〕
Net read: strategically constructive, but not a fresh earnings beat. The presentation supports a growth-and-exploration narrative and preserves production guidance, yet the central financial change is a 24% higher capex midpoint with no corresponding 2026 production uplift. Because the spending increase was already public, this lands as a priced-in, mixed guidance update rather than a new positive surprise.
Read the original 8-K on SEC EDGAR ↗